Rockwell Medical Inc. is a publicly traded (NASDAQ: RMTI) biopharmaceutical company founded in 1996 in Michigan. Rockwell focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD). This company performed top during ...
Kidney Disease. Diseases of the kidney are a major health concern in the United States, affecting more than 30 million Americans and causing more than 100,000 deaths annually. Learn more. Investor Center. Rockwell Medical's common shares are traded on NASDAQ under the symbol RMTI. More ›› ...
Investor Relations. Rockwell Medical is a public company trading on the NASDAQ Exchange under the symbol RMTI.
Rockwell Medical has a reputation as an industry innovator with an extensive history of product development and successful new product launches, addressing ...
Rockwell Medical is a fully-integrated biopharmaceutical company targeting end- stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. Rockwell's new innovative therapy Triferic is the ...
Careers. Rockwell's commitment to improving patient outcomes with innovative critical drug therapies and high-quality hemodialysis concentrates has driven us ...
Rockwell Medical Inc. stock price, stock quotes and financial overviews from MarketWatch.
Stock analysis for Rockwell Medical Inc (RMTI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
View the basic RMTI stock chart on Yahoo Finance. Change the date range, chart type and compare Rockwell Medical, Inc. against other companies.